Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis

Abstract

EPSTEiN-Barr virus (EBV), a human herpesvirus, establishes a persistent asymptomatic infection of the circulating B-lymphocyte pool1–3. The mechanism of virus persistence is not understood but, given the limited lifespan of most B cells in vivo, it seems most likely that EBV-infected cells must gain access to the long-lived memory B-cell pool. Here we show in an in vitro system that EBV, through expression of the full set of eight virus-coded 'latent' proteins, can protect human B cells from programmed cell death (apoptosis), the deletion mechanism which normally restricts entry into memory4. We have found that EBV-positive Burkitt's lym-phoma (BL) cell clones5 retaining the original tumour cell phenotype and expressing only one of the virus latent proteins, the nuclear antigen EBNA 1, are extremely sensitive to apoptosis; in this respect they resemble the tumour's normal cell of origin found in the germinal centres of lymphoid tissue. By contrast, isogenic BL cell clones which have activated expression of all eight EBV latent proteins are resistant to the induction of apoptosis. The EBV latent proteins should therefore be seen not just as activators of B-cell proliferation but, perhaps more importantly, as mediators of enhanced B-cell survival.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Nilsson, K., Klein, G., Henle, W. & Henle, G. Int. J. Cancer 8, 443–450 (1971).

    Article  CAS  Google Scholar 

  2. Gratama, J. W. et al. Proc. natn. Acad. Sci. U.S.A. 85, 8693–8696 (1988).

    Article  CAS  ADS  Google Scholar 

  3. Yao, Q. Y., Ogan, P., Rowe, M., Wood, M. & Rickinson, A. B. Int. J. Cancer 43, 67–71 (1989).

    Article  CAS  Google Scholar 

  4. Liu, Y-J. et al. Nature 342, 929–931 (1989).

    Article  CAS  ADS  Google Scholar 

  5. Gregory, C. D., Rowe, M. & Rickinson, A. B. J. gen. Virol. 71, 1481–1495 (1990).

    Article  CAS  Google Scholar 

  6. Rowe, M. et al. Int. J. Cancer 35, 435–442 (1985).

    Article  CAS  Google Scholar 

  7. Rooney, C. M. et al. J. natn. Cancer Inst. 77, 681–687 (1986).

    Article  CAS  Google Scholar 

  8. Rowe, M. et al. EMBO J. 6, 2743–2751 (1987).

    Article  CAS  Google Scholar 

  9. Wyllie, A. H. Int. Rev. Cytol. 68, 252–305 (1981).

    Google Scholar 

  10. Wyllie, A. H. Nature 284, 555–556 (1980).

    Article  CAS  ADS  Google Scholar 

  11. McConkey, D. J., Orrenius, S. & Jondal, M. Immun. Today 11, 120–121 (1990).

    Article  CAS  Google Scholar 

  12. Smith, C. A., Williams, G. T., Kingston, R., Jenkinson, E. J. & Owen, J. J. T. Nature 337, 181–184 (1989).

    Article  CAS  ADS  Google Scholar 

  13. Wyllie, A. H., Morris, R. G., Smith, A. L. & Dunlop, D. J. Path. 142, 67–77 (1984).

    Article  CAS  Google Scholar 

  14. Calender, A. et al. Proc. natn. Acad. Sci. U.S.A. 84, 8060–8064 (1987).

    Article  CAS  ADS  Google Scholar 

  15. Berard, C. W. in Burkitt's Lymphoma: A Human Cancer Model IARC Scient. Pub. No. 60 (eds Lenoir, G., O'Connor, G. & Olweny, C. L. M.) 31–35 (IARC, Lyon, 1985).

    Google Scholar 

  16. Mann, R. B. et al. New Engl. J. Med. 295, 685–691 (1976).

    Article  CAS  Google Scholar 

  17. Gregory, C. D. et al. J. Immun. 139, 313–318 (1987).

    CAS  PubMed  Google Scholar 

  18. MacLennan, I. C. M., Liu, Y-J., Oldfield, S., Zhang, J. & Lane, P. J. L. Curr. Topics microbiol. immun. 159, 37–63 (1990).

    CAS  Google Scholar 

  19. Pennell, C. A. & Scott, D. W. Eur. J. Immun. 16, 1577–1581 (1986).

    Article  CAS  Google Scholar 

  20. Hasbold, J. & Klaus, G. G. B. Eur. J. Immun. 20, 1685–1690 (1990).

    Article  CAS  Google Scholar 

  21. Yates, J., Warren, N., Reisman, D. & Sugden, B. Proc. natn. Acad. Sci. U.S.A. 81, 3806–3810 (1984).

    Article  CAS  ADS  Google Scholar 

  22. McConkey, D. J., Hartzell, P., Duddy, S. K., Hakansson, H. & Orrenius, S. Science 242, 256–258 (1989).

    Article  ADS  Google Scholar 

  23. Arends, M. J., Morris, R. G. & Wyllie, A. H. Am. J. Path. 136, 593–608 (1990).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gregory, C., Dive, C., Henderson, S. et al. Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis. Nature 349, 612–614 (1991). https://doi.org/10.1038/349612a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/349612a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing